Here's why Pfizer is revising its revenue forecasts

Core Viewpoint - The drugmaker has revised its revenue guidance for 2025, now expecting $62 billion in revenue for the year [1] Summary by Category - Revenue Guidance - The company anticipates a revenue of $62 billion for the year 2025 [1]